Acromegaly: What You Need to Know

What is Acromegaly?

Acromegaly is a rare, chronic hormonal disorder that results from excess production of growth hormone (GH) after the growth plates have closed. The surplus GH stimulates the liver to release insulin‑like growth factor‑1 (IGF‑1), which causes the bones of the face, hands, feet, and internal organs to enlarge over time. Because the condition develops slowly, many people do not recognize the changes until they become pronounced.

According to the Mayo Clinic, the average age at diagnosis is 40–45 years, and the prevalence is roughly 40–70 cases per million people worldwide.

Common Causes

In >95 % of cases, acromegaly is caused by a benign tumor (adenoma) in the pituitary gland that secretes GH. However, other less common conditions can produce similar hormonal excess.

• Pituitary adenoma – the most frequent cause; usually a somatotroph adenoma.
• Giant cell tumor of the pancreas – secretes GH‑releasing hormone (GHRH) that stimulates the pituitary.
• Ectopic GHRH‑secreting tumors – typically found in the bronchus, thymus, or neuroendocrine tumors.
• McCune‑Albright syndrome – a genetic disorder causing autonomous endocrine activity, including GH excess.
• Carney complex – multiple neoplasia syndrome that can involve pituitary GH‑producing adenomas.
• Hypothalamic hamartoma – rare lesion that can increase GHRH output.
• Multiple endocrine neoplasia type 1 (MEN1) – predisposes to pituitary adenomas.
• Familial isolated pituitary adenoma (FIPA) – inherited mutations (e.g., AIP gene) leading to GH‑secreting tumors.
• Idiopathic GH hypersecretion – cases where no tumor or identifiable cause is found.
• Acromegaly due to chronic liver disease – rare; reduced GH clearance leads to elevated IGF‑1.

Associated Symptoms

Because GH excess affects many organ systems, patients often experience a constellation of signs that progress gradually.

• Enlarged hands and feet (shoe size increase, ring size change)
• Facial changes – protruding brow, enlarged nose, thickened lips, and spaced teeth
• Joint pain and limited mobility due to cartilage overgrowth
• Headaches (often from tumor mass effect)
• Vision problems – especially peripheral field loss (bitemporal hemianopsia)
• Excessive sweating and oily skin
• Sleep apnea from enlarged airway tissues
• Cardiovascular complications – hypertension, left ventricular hypertrophy, arrhythmias
• Metabolic disturbances – insulin resistance, type 2 diabetes mellitus
• Enlarged organs (organomegaly) – especially heart, liver, and kidneys
• Carpal tunnel syndrome

These symptoms may be mistaken for normal aging or other conditions, contributing to delayed diagnosis.

When to See a Doctor

Because early treatment can prevent irreversible changes, be proactive if you notice any of the following:

• Sudden increase in shoe or ring size over months
• Persistent headaches not relieved by over‑the‑counter meds
• Changes in facial appearance (broader jaw, deeper voice)
• Unexplained joint pain or swelling
• Frequent episodes of sleep apnea or snoring that worsen
• New‑onset high blood pressure or glucose intolerance
• Visual disturbances, especially loss of peripheral vision

If any of these are present, schedule an appointment with an endocrinologist or primary‑care physician promptly.

Diagnosis

Diagnosis relies on clinical suspicion, biochemical testing, and imaging.

Biochemical Evaluation

• Serum IGF‑1 level – age‑adjusted reference range; elevated in >95 % of patients.
• Oral glucose tolerance test (OGTT) – normally suppresses GH < 1 µg/L; failure to suppress is diagnostic.
• Random GH measurements – may be intermittently elevated; multiple samples improve accuracy.

Imaging

• Magnetic resonance imaging (MRI) of the pituitary with contrast is the gold standard for locating adenomas (detects tumors as small as 2 mm).
• CT scan – used when MRI is contraindicated.
• Visual field testing – assesses compressive effects on the optic chiasm.

Additional Tests

• Electrocardiogram and echocardiogram to evaluate cardiac involvement.
• Polysomnography if sleep apnea is suspected.
• Bone density scan (DEXA) to detect secondary osteoporosis.

Treatment Options

Treatment aims to normalize GH/IGF‑1 levels, reduce tumor size, and manage complications. A combination of surgery, medication, and lifestyle changes is often required.

Surgical Management

• Transsphenoidal pituitary adenomectomy – first‑line for most micro‑ (<10 mm) and many macro‑adenomas; success depends on tumor size and invasiveness.
• Endoscopic approaches have reduced recovery time and improve visualization.

Medical Therapy

• Somatostatin analogues (octreotide, lanreotide) – bind to somatostatin receptors, decreasing GH secretion; can shrink tumors in ~30 % of patients.
• GH receptor antagonist (pegvisomant) – blocks IGF‑1 production; particularly useful when somatostatin analogues are ineffective.
• Dopamine agonists (cabergoline, bromocriptine) – modest GH reduction; may be added for combined therapy.
• Medication selection is individualized based on tumor size, IGF‑1 levels, side‑effect profile, and patient preference.

Radiation Therapy

• Indicated when surgery and medication fail to achieve control.
• Options include conventional fractionated radiotherapy and stereotactic radiosurgery (Gamma Knife, CyberKnife).
• Hormonal control may take several years; risk of hypopituitarism exists.

Home & Lifestyle Strategies

• Maintain a balanced diet low in simple sugars to help control insulin resistance.
• Regular aerobic exercise (150 min/week) supports cardiovascular health.
• Weight management can lessen sleep‑apnea severity.
• Monitor blood pressure and blood glucose at home; keep a log for your doctor.
• Stay up‑to‑date with ophthalmology and cardiology follow‑ups.

Prevention Tips

Acromegaly itself cannot be "prevented" in most cases because it usually arises from a spontaneous pituitary adenoma. However, certain steps can reduce the risk of complications and facilitate earlier detection:

• Annual physical examinations that include measurement of shoe/ring size for adults over 30.
• Prompt evaluation of persistent headaches or visual changes.
• Control modifiable risk factors – hypertension, obesity, and diabetes – which can exacerbate disease impact.
• For individuals with a family history of pituitary tumors (e.g., MEN1, FIPA), consider genetic counseling and periodic MRI screening.
• Avoid long‑term exposure to radiation of the head/neck unless medically necessary.

Emergency Warning Signs

Key Take‑aways

Acromegaly is a treatable yet potentially serious condition. Early recognition of subtle changes—such as growing shoe sizes, facial enlargement, or persistent headaches—allows timely diagnostic testing and intervention, which can halt disease progression and markedly improve quality of life. Regular follow‑up with an endocrinologist, alongside a healthy lifestyle, remains the cornerstone of long‑term management.

For more information, consult reputable sources such as the CDC, NIH, WHO, and the Cleveland Clinic.